Wells Fargo & Company Surmodics Inc Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Surmodics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 7,032 shares of SRDX stock, worth $239,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,032
Previous 4,991
40.89%
Holding current value
$239,791
Previous $193,000
44.04%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SRDX
# of Institutions
140Shares Held
12.6MCall Options Held
28.2KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$39.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.01MShares$34.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA803KShares$27.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY675KShares$23 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X0454KShares$15.5 Million0.02% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $478M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...